spacer
home > epc > summer 2002 > making the right choice in pharmaceutical outsourcing
PUBLICATIONS
European Pharmaceutical Contractor

Making the Right Choice in Pharmaceutical Outsourcing

Outsourcing of analysis within the pharmaceutical industry has steadily increased in recent years and this trend seems set to continue with estimated growth being as high as 9 per cent per annum.

Key reasons for outsourcing analysis include:

Little or no facilities in-house

Utilisation of internal competence on higher value return science, such
as better value for money from internal staff

In-house capacity problems due to increased testing in line with regulations

The problem of choosing the right outsourcing partner has been exacerbated by the growth in the number of contract service organisations (CSOs) on the market. Often these organisations appear to offer similar services and returns for the customer - thus making the partnering decision difficult.

This article will explore four key areas worthy of consideration when selecting your outsourcing laboratory.

Balancing Cost and Confidence

When faced with the prospect of outsourcing you must be convinced of the viability and robustness of your decision to hand over control of a project to a third party. As the project manager, you must be confident about getting value for money, quality and delivery from your outsourcing partner.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Brian Arnot, Business Development Executive at Tepnel Scientific Services

Brian Arnot is an experienced Analytical Chemist who has worked in the contract analytical services sector since 1984.

More recently, he has joined the business development team of Tepnel Scientific Services (formerly the Medicines Testing Laboratory), where he is responsible for the development of core business activities in both the UK and Europe.

spacer
Brian Arnot
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement